Track Curaleaf Holdings, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Curaleaf Holdings, Inc. CURLF · Stock Open Curaleaf Holdings, Inc. in new tab

7.85 USD
EPS
-0.05
P/B
2.77
ROE
-0.50
Beta
1.76
Target Price
16.00 USD
Curaleaf Holdings, Inc. logo

Curaleaf Holdings, Inc.

🧾 Earnings Recap – Q3 2025

Curaleaf Holdings reported a stable third quarter with $320 million in revenue, showcasing resilience amidst price compression while achieving significant growth in its international segment.

  • Revenue increased by 2% sequentially, with the international segment experiencing robust 12% sequential growth and 56% year-over-year growth.
  • Adjusted gross margins improved to 50%, reflecting a 115 basis point increase, while adjusted EBITDA stood at $69 million, yielding a 22% margin.
  • The company strengthened its balance sheet by closing a $100 million revolving credit line, providing enhanced operational flexibility.
  • Average flower potency surpassed 30% for the first time, aided by improved cultivation techniques and genetics.
  • The launch of innovative products such as the Anthem pre-roll brand is gaining traction, significantly contributing to sales and brand awareness.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 25, 2027
EPS-0.05
Book Value3.20
Price to Book2.77
Debt/Equity133.56
% Insiders25.776%
Growth
Revenue Growth0.11%
Estimates
Forward P/E-21.12
Forward EPS-0.42
Target Mean Price16.00

DCF valuation

Model fair value for Curaleaf Holdings, Inc. (CURLF)
Result
Sign in to run the valuation for CURLF.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
2 analysts · consensus Strong buy · mean target 16.00 USD (low 15.00, high 17.00) · as of 12 Nov 2026
Low 15.00
Mean 16.00
High 17.00
Price 7.85
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Curaleaf Holdings, Inc. Logo Curaleaf Holdings, Inc. Analysis (CURLF)

United States Health Care Official Website Stock

Is Curaleaf Holdings, Inc. a good investment? Curaleaf Holdings, Inc. (CURLF) is currently trading at 7.85 USD. Market analysts have a consensus price target of 16.00 USD. This suggests a potential upside from current levels.

Earnings Schedule: Curaleaf Holdings, Inc. is expected to release its next earnings report on Feb. 25, 2027. The market consensus estimate for Forward EPS is -0.42.

Investor FAQ

Does Curaleaf Holdings, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Curaleaf Holdings, Inc.?

Curaleaf Holdings, Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 25, 2027. The company currently has a trailing EPS of -0.05.

Company Profile

Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway. In addition, the company operates a medical cannabis clinic and holds a pharmacy license. It serves the medical and adult-use cannabis markets through retail and wholesale channels. The company is based in Stamford, Connecticut.

Exchange Ticker
CNQ (Canada) CURA.CN
CURA.TO
PNK (United States) CURLF
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
June 5, 2026 0.33
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion